Statements Author contributions SS: Conceptualization, Funding acquisition, Investigation, Writing original draft, Writing review and editing
A recent study found that GLP-1 analogs improve the mental health of patients receiving treatment for type 2 diabetes and obesity
CMS should closely monitor prior authorizations and denials to ensure patients can access GLP-1s
Enter pharmaceutical interventions that promise to tip the scales (literally) in favor of sustainable weight management
At the start of 2026, Blue Cross Blue Shield of Massachusetts dropped coverage of GLP-1s for obesity treatment for employers with fewer than 100 employees
They may come from different stages of food-related processing, including basic sensory changes, altered pleasure during eating, or reduced motivation in response to food cues (11)